• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性呼吸道乳头状瘤病中HLA-DQ3表型富集及I类主要组织相容性复合体抗原表达降低

Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis.

作者信息

Bonagura V R, Siegal F P, Abramson A L, Santiago-Schwarz F, O'Reilly M E, Shah K, Drake D, Steinberg B M

机构信息

Department of Pediatrics, Schneider Children's Hospital, New Hyde Park, New York 11042, USA.

出版信息

Clin Diagn Lab Immunol. 1994 May;1(3):357-60. doi: 10.1128/cdli.1.3.357-360.1994.

DOI:10.1128/cdli.1.3.357-360.1994
PMID:7496977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC368263/
Abstract

Respiratory papillomas, caused by human papillomaviruses, are benign tumors that recur following removal. We evaluated immune function and major histocompatibility complex (MHC) phenotype and expression in these patients. MHC-independent immune function appeared normal. The frequency of peripheral blood MHC class II phenotypes was highly enriched for DQ3 and DR11, one split of DR5. Class I MHC antigen expression on papilloma tissue was markedly reduced. Together, these phenomena may facilitate papillomavirus evasion of the cellular immune response.

摘要

由人乳头瘤病毒引起的呼吸道乳头瘤是切除后会复发的良性肿瘤。我们评估了这些患者的免疫功能以及主要组织相容性复合体(MHC)的表型和表达情况。不依赖MHC的免疫功能看起来正常。外周血MHC II类表型的频率在DQ3和DR11(DR5的一个分支)中高度富集。乳头瘤组织上I类MHC抗原的表达明显降低。这些现象共同作用可能会促使乳头瘤病毒逃避免疫细胞反应。

相似文献

1
Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病中HLA-DQ3表型富集及I类主要组织相容性复合体抗原表达降低
Clin Diagn Lab Immunol. 1994 May;1(3):357-60. doi: 10.1128/cdli.1.3.357-360.1994.
2
HLA class II antigen expression in human papillomavirus-associated cervical cancer.人乳头瘤病毒相关宫颈癌中HLA II类抗原的表达
Cancer Res. 1992 Jul 15;52(14):4009-16.
3
Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.主要组织相容性复合体II类抗原HLA-DR和-DQ的表达与甲状腺乳头状癌复发的意义。
Int J Cancer. 2008 Feb 15;122(4):785-90. doi: 10.1002/ijc.23167.
4
Immunocompetency in children with recurrent respiratory papillomatosis: prospective study.复发性呼吸道乳头状瘤病患儿的免疫能力:前瞻性研究
Ann Otol Rhinol Laryngol. 2007 Mar;116(3):169-71. doi: 10.1177/000348940711600302.
5
Downregulation of major histocompatibility complex class I in bovine papillomas.牛乳头瘤中主要组织相容性复合体I类的下调
J Gen Virol. 2004 Oct;85(Pt 10):2809-2814. doi: 10.1099/vir.0.80128-0.
6
Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.主要组织相容性复合体I类和II类抗原在弥漫性大细胞和大细胞免疫母细胞淋巴瘤中的表达。抗原表达与临床结果之间不存在相关性。
Am J Pathol. 1993 Oct;143(4):1086-97.
7
Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease.喉乳头状瘤病中TAP-1和主要组织相容性复合体I类的表达改变:TAP-1与疾病的相关性
Clin Diagn Lab Immunol. 2000 Jan;7(1):79-85. doi: 10.1128/CDLI.7.1.79-85.2000.
8
Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance.
Clin Immunol. 1999 Dec;93(3):302-11. doi: 10.1006/clim.1999.4784.
9
Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.宫颈癌:西班牙人群中的人乳头瘤病毒感染及HLA相关风险因素
Eur J Immunogenet. 1998 Oct;25(5):329-37.
10
HLA in Singapore Chinese with rheumatoid arthritis.新加坡华裔类风湿关节炎患者的人类白细胞抗原
J Rheumatol. 1992 Oct;19(10):1517-9.

引用本文的文献

1
Major Human Leukocyte Antigen Expression in Respiratory Papillomatosis Clinical Specimens.呼吸道乳头状瘤病临床标本中的主要人类白细胞抗原表达
Laryngoscope. 2025 Aug;135(8):2824-2830. doi: 10.1002/lary.32121. Epub 2025 Mar 13.
2
Molecular Mechanisms of Carcinogenesis in Pediatric Airways Tumors.小儿气道肿瘤发生的分子机制。
Int J Mol Sci. 2023 Jan 22;24(3):2195. doi: 10.3390/ijms24032195.
3
Trace Elements Levels in Serum of Patients with Recurrent Respiratory Papillomatosis.复发性呼吸道乳头状瘤病患者血清中的微量元素水平

本文引用的文献

1
Papilloma of the larynx: a review of 109 cases with a preliminary report of aureomycin therapy.喉乳头状瘤:109例病例回顾及金霉素治疗初步报告
Ann Otol Rhinol Laryngol. 1950 Jun;59(2):547-64. doi: 10.1177/000348945005900225.
2
Culture of human laryngeal papilloma cells in vitro.人喉乳头瘤细胞的体外培养。
Otolaryngol Head Neck Surg. 1982 Nov-Dec;90(6):728-35. doi: 10.1177/019459988209000610.
3
The transporters associated with antigen presentation.与抗原呈递相关的转运蛋白。
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):5037-5043. doi: 10.1007/s12070-021-02676-9. Epub 2021 Jun 11.
4
A review of the risk factors associated with juvenile-onset recurrent respiratory papillomatosis: genetic, immune and clinical aspects.青少年复发性呼吸道乳头瘤病相关危险因素的研究进展:遗传、免疫和临床方面。
World J Pediatr. 2022 Feb;18(2):75-82. doi: 10.1007/s12519-021-00496-z. Epub 2022 Jan 24.
5
How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.如何增强对低危型 HPV 的免疫力以治愈复发性呼吸道乳头瘤病。
Laryngoscope. 2021 Sep;131(9):2041-2047. doi: 10.1002/lary.29153. Epub 2021 Mar 15.
6
Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP).复发性呼吸道乳头瘤病(RRP)患者的单核细胞和朗格汉斯细胞固有免疫改变。
Front Immunol. 2020 Mar 10;11:336. doi: 10.3389/fimmu.2020.00336. eCollection 2020.
7
Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.复发性呼吸道乳头瘤病中低危型 HPV 的免疫耐受。
Clin Exp Immunol. 2020 Feb;199(2):131-142. doi: 10.1111/cei.13387. Epub 2019 Oct 31.
8
Current and future management of recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病的当前及未来管理
Laryngoscope Investig Otolaryngol. 2018 Jan 14;3(1):22-34. doi: 10.1002/lio2.132. eCollection 2018 Feb.
9
The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病中的PD-1和PD-L1通路。
Laryngoscope. 2018 Jan;128(1):E27-E32. doi: 10.1002/lary.26847. Epub 2017 Sep 22.
10
Lymphocyte profile and cytokine mRNA expression in peripheral blood mononuclear cells of patients with recurrent respiratory papillomatosis suggest dysregulated cytokine mRNA response and impaired cytotoxic capacity.复发性呼吸道乳头瘤病患者外周血单个核细胞中的淋巴细胞谱和细胞因子 mRNA 表达提示细胞因子 mRNA 反应失调和细胞毒性能力受损。
Immun Inflamm Dis. 2017 Dec;5(4):541-550. doi: 10.1002/iid3.188. Epub 2017 Aug 14.
Semin Cell Biol. 1993 Feb;4(1):53-61. doi: 10.1006/scel.1993.1007.
4
HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.人乳头瘤病毒感染与宫颈原位癌中HLA的表达
Eur J Cancer. 1993;29A(14):1963-70. doi: 10.1016/0959-8049(93)90453-m.
5
Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病患者的自然细胞毒性和干扰素产生
Ann Otol Rhinol Laryngol. 1984 Sep-Oct;93(5 Pt 1):483-7. doi: 10.1177/000348948409300514.
6
T-cell subsets and Langerhans cells in wart lesions.
Immunol Lett. 1983 Apr;6(4):191-6. doi: 10.1016/0165-2478(83)90002-0.
7
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.生殖器和喉乳头状瘤以及某些宫颈癌中的人乳头瘤病毒6型和11型DNA序列。
Proc Natl Acad Sci U S A. 1983 Jan;80(2):560-3. doi: 10.1073/pnas.80.2.560.
8
Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx.青少年及成人喉鳞状乳头状瘤的病毒病因学
Proc Natl Acad Sci U S A. 1982 Sep;79(17):5425-9. doi: 10.1073/pnas.79.17.5425.
9
Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent.利用单克隆抗体(Q5/13)免疫吸附剂纯化人Ia样抗原的免疫功能亚群。
J Immunol. 1980 Oct;125(4):1421-5.
10
Histocompatibility-linked immune response genes.组织相容性连锁免疫反应基因
Science. 1972 Jan 21;175(4019):273-9. doi: 10.1126/science.175.4019.273.